Document ID: chunk:federal_register_of_legislation:F2024C01228:reg:222
Version: federal_register_of_legislation:F2024C01228
Segment Type: reg
Provision Reference: reg 222
Character Range: 122189–124345

222    Vaccine                                                                                                                                                                                                                                                                                                                                Abrysvo                          Injection (0.5mL)                                           Each 0.5mL dose contains 120 µg of stabilised prefusion F proteins (60 µg  RSV‑A and 60 µg  RSV‑B antigens)  1 dose:
       respiratory syncytial virus (RSV) stabilised prefusion F subunit                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   (a) at 28 to 36 weeks gestation; or
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          (b) after 36 weeks gestation, if vaccination is two weeks prior to birth.
       Circumstances
       Vaccine may be provided to a person who is pregnant

Part 3 Combined bacterial and viral vaccines
Item   Vaccine and the circumstances in which vaccine may be provided                                                             Brand           Formulation                         Active ingredient and strength                                                           Number and timing of doses